Appili Therapeutics Overview
- Founded
- 2015

- Status
- Public
- Employees
- 13

- Stock Symbol
- APLI

- Investments
- 1
- Share Price
- $0.86
- (As of Friday Closing)
Appili Therapeutics General Information
Description
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.
Contact Information
- 1344 Summer Street
- Suite 21
- Halifax, Nova Scotia B3H 0A8
- Canada
Appili Therapeutics Timeline
Appili Therapeutics Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.86 | $0.87 | $0.35 - $1.36 | $54.5M | 62.6M | 135K | -$0.12 |
Appili Therapeutics Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 |
---|---|---|---|---|
EV | 44,152 | 21,156 | ||
Revenue | 148 | 150 | 0 | 0 |
EBITDA | (5,591) | (4,049) | (3,315) | (2,921) |
Net Income | (5,603) | (4,071) | (3,299) | (3,097) |
Total Assets | 17,722 | 7,879 | 5,119 | 5,568 |
Total Debt | 757 | 709 | 838 | 861 |
Appili Therapeutics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Appili Therapeutics‘s full profile, request access.
Request a free trialAppili Therapeutics Comparisons
Industry
00000000
00000 00
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAppili Therapeutics Competitors (31)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Morphotek | Formerly VC-backed | Exton, PA | 000 | 0000 | 000000&0 | 0000 |
00000 000000000 | Formerly VC-backed | Boulder, CO | 000 | 00000 | 000000&0 | 00000 |
00000 00000 000000 | Venture Capital-Backed | Geneva, Switzerland | 00 | 00000 | 0000000000 0 | 00000 |
00000 000000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 000.00 | 000000 - 000 | 000.00 |
00000000 000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000 - | 00000 |
Appili Therapeutics Executive Team (9)
Appili Therapeutics Board Members (14)
Name | Representing | Role | Since |
---|---|---|---|
Armand Balboni Ph.D | Appili Therapeutics | Chief Executive Officer & Board Member | 000 0000 |
Brian Bloom | Bloom Burton & Co. | Board Member | 000 0000 |
Ian Mortimer | Self | Chairman & Board Member | 000 0000 |
John Holyoake Ph.D | Bloom Burton & Co. | Board Member | 000 0000 |
Juergen Froehlich MD | Appili Therapeutics | Board Member | 000 0000 |
Appili Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAppili Therapeutics Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 00000000 (0 | 21-Nov-2019 | 000000000 00000 00 | Buildings and Property | 00000 00000000 |